for Oncogene. Oh, I know, we authors always try to thank reviewers in our rebuttal letters in the hope that they will be lenient, but we can do it again, now, with no 'April Fooling', and recognize all of those who take time out of their busy schedules to perform this invaluable service. Thank you, thank you, thank you.
We have reorganized things a bit, as you'll notice. We have enlisted the help of an outstanding group of Deputy Editors who are truly leaders in this field. The Deputy Editors will perform initial evaluations of the submissions to ensure that we focus time and effort on those contributions that will advance the literature, while returning those that might need a bit more work or might fare better elsewhere. We have similarly recruited our outstanding Receiving Editors, again notable leaders, who will further evaluate the papers and solicit advice from reviewers in rendering decisions. I look forward to working with this fabulous group to provide the speediest responses to your submitted papers.
Of course, I want to encourage you to send us your most exciting work, and to assure you that we will read it, think about it and provide the best advice we can, and hopefully publish it in a journal that will continue to be of the greatest interest to our colleagues. And I want to encourage you to read those papers, because these will be a source of novel findings and ideas in this continually evolving field. This is a good time to open up that file we laid aside, called 'scope.' Oncogene focuses on all aspects of the molecular basis of cancer and all of those related areas that are crucial to understanding this disease. These include oncogenes and their proteins, obviously, but also the functions of tumor suppressors, cell cycle control, growth factors and their receptors, immortilization and senescence, cell death and cell growth, as well as other areas that relate to the molecular mechanisms of cellular homeostasis. As your research provides new insights into such processes, please keep Oncogene in mind.
I'll end here with a simple apology, in advance, for all of the mistakes I will undoubtedly make and for which I already take responsibility. I am the April Fish, and I do think that this is the new year. But I am a quick learner, I hope. Do let me know if we manage to get something right, what we have gotten wrong and how we can do better. Our mission is to ensure that Oncogene is a journal that you will read, learn from, work with and publish in, and I am very thankful for the opportunity to make this happen.
DR Green, PhD
Editor-in-Chief Oncogene 
